B of A Securities analyst Tal Liani downgrades F5 (NASDAQ:FFIV) from Buy to Neutral.
Medtronic Says New Data For MiniMed 780G Supports Use In Children With Diabetes
Medtronic plc (NYSE: MDT) presented new clinical and real-world data on the MiniMed 780G system at the 83rd American Diabetes